Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
ADIL•Inducement grant announcement
Aug. 25 (Reuters) - Adial Pharmaceuticals Inc. (NASDAQ: ADIL):
- Adial Pharmaceuticals announces inducement grant under Nasdaq Listing Rule 5635(c)(4).
Related News
Spyre Therapeutics Announces Topline Results From The Rheumatoid Arthritis Sub-Study Of The Skyway Phase 2 Trial Of Spy072
SYRE•
Aon-Jacobson study shows 49% of US insurers plan staff increases in next 12 months
AON•
